Heron Therapeutics, Inc. (HRTX) Social Stream



Heron Therapeutics, Inc. (HRTX): $3.10

-0.06 (-1.90%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

Add HRTX to Watchlist
Sign Up

Industry: Biotech


Ranked

of 392

in industry

Heron Therapeutics Inc (HRTX) Price Targets From Analysts

The tables below show price targets and recommendations from analysts covering Heron Therapeutics Inc.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Current Price Upside Potential
2021-12-10 3 $60 $23 $33 $5.54 495.67%
2022-03-01 4 $60 $23 $33 $5.54 495.67%
2022-03-02 4 $60 $13 $27.2 $5.54 390.97%

The Trend in the Analyst Price Target


Over the past 14 months, HRTX's average price target has gone down $4.9.

Over the past 48 weeks, HRTX's average upside potential has been 184.86%.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Share Price Upside Potential
2021-04-10 3 70 25 34.00 16.60 104.82%
2021-06-26 3 70 22 32.89 16.62 97.89%
2021-07-10 8 70 25 34.25 14.02 144.29%
2021-09-11 7 60 23 33.00 11.65 183.26%
2021-12-10 3 60 23 33.00 9.02 265.85%

HRTX Broker Recommendations Summary

Average Broker Rating Strong Buy Buy Hold Sell Strong Sell Analysts Issuing Recs
1 4 0 0 0 0 4

The Trend in the Broker Recommendations


Over the past 22 months, HRTX's average broker recommendation rating improved by 0.

The bullet points below may help you gain a better understanding of what the metrics in the price target and recommendations tables above mean for HRTX as an investment opportunity.

  • To contextualize these metrics, consider that out of all US stocks, Heron Therapeutics Inc's variance in analysts' estimates is lower than -284.9% of them.
  • In terms of how Heron Therapeutics Inc fares relative to all US stocks, note that its upside potential (average analyst target price relative to current price) is higher than 383% of that group.
  • In the context of stocks in the mid market cap category, Heron Therapeutics Inc's number of analysts covering the stock is greater than 55.37% of them.
  • In the context of stocks in the mid market cap category, Heron Therapeutics Inc's average analyst price target is greater than 144.73% of them.

Stocks similar to Heron Therapeutics Inc in the Pharmaceutical Products industry regarding analyst recommendations and price targets are HRMY, HCM, and GBT.

Is HRTX a Buy, Hold or Sell? See the POWR Ratings now!


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!




Page generated in 0.5186 seconds.